TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition

02 ноя 2023 09:05:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting

27 сен 2023 09:06:51 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME

29 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

10 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Transition of Chief Financial Officer

29 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors

06 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the 2023 American Society of Clinical Oncology Annual Meeting

01 июн 2023 16:10:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Closing of Public Offering

01 июн 2023 16:05:35 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Jefferies Healthcare Conference

01 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Pricing of $140 Million Public Offering

26 май 2023 00:37:03 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Launch of Proposed Public Offering

25 май 2023 16:06:50 Источник Nasdaq GlobeNewswire

TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors

24 май 2023 16:13:47 Источник Nasdaq GlobeNewswire

TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy 26th Annual Meeting

17 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

10 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

09 май 2023 09:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting

02 май 2023 16:42:10 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors

10 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces CEO Transition

31 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces First Patient Dosed in Phase 1 Umbrella Clinical Trial Evaluating TSC-100 and TSC-101 for the Treatment of Hematologic Malignancies

14 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Barclays Global Healthcare Conference

13 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire